Is the big pharma business the next industry to face the melt down and consolidation process? BioTech investments are growing, and personalized medicine will also have an impact as activity continues to grow. Sequencing machines and technology are also bringing that portion of the industry down to an affordable level. BD
The pharma industry, like many other industries in the down U.S. economy, is due to consolidate. Big Pharma is facing a slew of patent expirations from some of the most profitable drugs in history in 2011 and 2012, leaving many large pharmaceuticals companies looking for acquisitions that will strengthen their pipeline and boost shares.